''A review has found that low levels of gadolinium can be retained in the brain and other tissues after administration of gadolinium-containing contrast agents (GdCAs). There is currently no ...'
''GE Healthcare is using Great Britain's notoriously stringent libel laws to sue a Danish physician over his remarks about its Omniscan MRI drug at a medical conference in Oxford, England. Libel laws in the U.K. provide litigants with deep pockets a ...'
''GE Healthcare has promoted a vigorous scientific debate about the safety of Gadolinium Based Contrast Agents (GBCAs), including Omniscan™ and we reject any suggestion to the contrary. Like the many other scientists who have contributed to this ...'
Sunday, 20 December 2009 by newsroom.gehealthcare.com
''The U.S. Food & Drug Administration is weighing further regulation of three drugs used to create high-contrast images on MRI scans, based on a new analysis that suggests they carry a higher risk of causing a rare, but potentially fatal disease. The ...'
Wednesday, 2 December 2009 by www.businessweek.com
•
News
top
